HRP20120278T1 - Polivalentni pripravak konjugata pneumokoknog polisaharida s proteinom - Google Patents

Polivalentni pripravak konjugata pneumokoknog polisaharida s proteinom Download PDF

Info

Publication number: HRP20120278T1
Authority: HR; Croatia
Prior art keywords: adjuvant; immunogenic preparation; aluminum; preparation according; protein
Prior art date: 2005-04-08

Application number

HR20120278T

Other languages

English (en)

Croatian (hr)

Inventor

P. Hausdorff William

Rainer Siber George

R. Paradiso Peter

Original Assignee

Wyeth Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-08

Filing date

2012-03-29

Publication date

2012-04-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36709976&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20120278(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-03-29 Application filed by Wyeth Llc filed Critical Wyeth Llc

2012-04-30 Publication of HRP20120278T1 publication Critical patent/HRP20120278T1/hr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

HR20120278T 2005-04-08 2012-03-29 Polivalentni pripravak konjugata pneumokoknog polisaharida s proteinom HRP20120278T1 (hr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US66960505P	2005-04-08	2005-04-08
PCT/US2006/012354 WO2006110381A1 (en)	2005-04-08	2006-03-31	Multivalent pneumococcal polysaccharide-protein conjugate composition

Publications (1)

Publication Number	Publication Date
HRP20120278T1 true HRP20120278T1 (hr)	2012-04-30

Family

ID=36709976

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20120278T HRP20120278T1 (hr)	2005-04-08	2012-03-29	Polivalentni pripravak konjugata pneumokoknog polisaharida s proteinom

Country Status (29)

Country	Link
US (9)	US20060228380A1 (de)
EP (9)	EP2425853A1 (de)
JP (3)	JP4472770B2 (de)
KR (11)	KR101730750B1 (de)
CN (6)	CN108404126B (de)
AR (2)	AR053354A1 (de)
AT (1)	ATE548051T1 (de)
AU (1)	AU2006235013B2 (de)
BR (1)	BRPI0607025B8 (de)
CA (4)	CA2878579C (de)
CL (2)	CL2016000566A1 (de)
CY (1)	CY1112777T1 (de)
DK (1)	DK1868645T3 (de)
ES (1)	ES2382048T3 (de)
HK (3)	HK1120416A1 (de)
HR (1)	HRP20120278T1 (de)
IL (5)	IL308456A (de)
ME (1)	ME01334B (de)
MX (3)	MX358148B (de)
MY (1)	MY145150A (de)
NZ (1)	NZ562406A (de)
PL (1)	PL1868645T3 (de)
PT (1)	PT1868645E (de)
RS (1)	RS52249B (de)
SA (1)	SA06270323B1 (de)
SI (1)	SI1868645T1 (de)
TW (3)	TWI386222B (de)
WO (1)	WO2006110381A1 (de)
ZA (1)	ZA200709483B (de)

Families Citing this family (138)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070184072A1 (en)	2005-04-08	2007-08-09	Wyeth	Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) *	2005-04-08	2010-05-04	Wyeth Llc	Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) *	2005-04-08	2011-06-07	Wyeth Llc	Multivalent pneumococcal polysaccharide-protein conjugate composition
WO2006110381A1 (en)	2005-04-08	2006-10-19	Wyeth	Multivalent pneumococcal polysaccharide-protein conjugate composition
PL1896065T5 (pl) *	2005-06-27	2014-12-31	Glaxosmithkline Biologicals Sa	Sposób wytwarzania szczepionek
SI2384765T1 (sl)	2005-12-22	2017-03-31	Glaxosmithkline Biologicals S.A.	Streptococcus pneumoniae vakcina
GB0607088D0 (en) *	2006-04-07	2006-05-17	Glaxosmithkline Biolog Sa	Vaccine
AU2013200552B9 (en) *	2006-04-07	2014-07-03	Glaxosmithkline Biologicals S.A.	Conjugate vaccines
AU2016204760A1 (en) *	2006-04-26	2016-07-28	Wyeth Llc	Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
AU2012216628B9 (en) *	2006-04-26	2021-10-21	Wyeth Llc	Novel Formulations which Stabilize and Inhibit Precipitation of Immunogenic Compositions
TW200806315A (en)	2006-04-26	2008-02-01	Wyeth Corp	Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
US8808707B1 (en)	2006-05-08	2014-08-19	Wyeth Llc	Pneumococcal dosing regimen
WO2008118752A2 (en)	2007-03-23	2008-10-02	Wyeth	Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
EP2155244B1 (de) *	2007-04-23	2017-03-22	Serum Institute of India Private Limited	Antigene polysaccharide und verfahren zu ihrer herstellung
PE20090212A1 (es) *	2007-05-02	2009-03-30	Glaxosmithkline Biolog Sa	Kit de vacuna para la inmunizacion primaria
MX2009013949A (es) *	2007-06-26	2010-05-24	Glaxosmithkline Biolog Sa	Vacuna que comprende conjugados de polisacárido capsular de streptococcus pneumoniae.
GB0713880D0 (en) *	2007-07-17	2007-08-29	Novartis Ag	Conjugate purification
GB0818453D0 (en) *	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
WO2009106085A1 (en) *	2008-02-28	2009-09-03	Nordic Vaccine A/S	Vaccine compositions comprising saccharide antigens
WO2009143413A1 (en) *	2008-05-22	2009-11-26	Children'smedical Center Corporation	Synergistic immunogenic fusion protein-polysaccharide conjugate
GB0822634D0 (en)	2008-12-11	2009-01-21	Novartis Ag	Meningitis vaccines
WO2010080484A1 (en) *	2008-12-18	2010-07-15	Wyeth Llc	Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon
PT2379734T (pt)	2008-12-18	2018-04-27	Wyeth Llc	Método para o controlo da massa molecular do polissacárido do serotipo 19a de streptococcus pneumoniae
LT2411048T (lt)	2009-03-24	2020-06-25	Glaxosmithkline Biologicals Sa	Adjuvantinį meningokokinį faktorių h surišantis baltymas
WO2010109324A1 (en)	2009-03-24	2010-09-30	Novartis Ag	Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
BRPI1014494A2 (pt) *	2009-04-30	2016-08-02	Coley Pharm Group Inc	vacina pneumocócica e usos da mesma
TW201136603A (en) *	2010-02-09	2011-11-01	Merck Sharp & Amp Dohme Corp	15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
CN101785857B (zh) *	2010-03-05	2012-09-26	成都安特金生物技术有限公司	一种新的肺炎球菌结合疫苗及其制备方法
GB201003924D0 (en)	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Immunogenic composition
GB201003922D0 (en)	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Conjugation process
WO2011148382A1 (en)	2010-05-28	2011-12-01	Biological E Limited	An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol.
HUE048398T2 (hu)	2010-06-04	2020-07-28	Wyeth Llc	Vakcinakészítmények
AU2011268507B2 (en)	2010-06-25	2014-08-14	Novartis Ag	Combinations of meningococcal factor H binding proteins
TR201811280T4 (tr)	2011-03-02	2018-08-27	Glaxosmithkline Biologicals Sa	Düşük antijen ve/ veya adjuvan dozları olan karma aşılar.
KR101315599B1 (ko) *	2011-10-25	2013-10-10	건국대학교 산학협력단	폐렴균점막다당질 유형14 （ｃｐｓ１４）와 호스래디시 퍼옥시다제의 당단백중합체
AU2011384634A1 (en)	2011-12-29	2014-06-19	Novartis Ag	Adjuvanted combinations of meningococcal factor H binding proteins
JP2015510872A (ja)	2012-03-07	2015-04-13	ノバルティスアーゲー	Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤
US20150125486A1 (en)	2012-03-08	2015-05-07	Novartis Ag	Adjuvanted formulations of pediatric antigens
KR102057217B1 (ko)	2012-06-20	2020-01-22	에스케이바이오사이언스 주식회사	다가 폐렴구균 다당류-단백질 접합체 조성물
WO2014009971A2 (en) *	2012-07-07	2014-01-16	Bharat Biotech International Limited	Non-alcoholic vaccine compositions free from animal- origin and process for preparation thereof
RU2645071C2 (ru)	2012-08-16	2018-02-15	Пфайзер Инк.	Способы гликоконъюгирования и композиции
CN104602705A (zh)	2012-09-06	2015-05-06	诺华股份有限公司	血清组b脑膜炎球菌和d/t/p的联合疫苗
US9636392B2 (en) *	2012-09-07	2017-05-02	Sk Chemical Co., Ltd.	Production method for capsular polysaccharide having pneumococcal serotype
KR20140075196A (ko)	2012-12-11	2014-06-19	에스케이케미칼주식회사	다가 폐렴구균 다당류-단백질 접합체 조성물
KR20140075201A (ko) *	2012-12-11	2014-06-19	에스케이케미칼주식회사	다가 폐렴구균 다당류-단백질 접합체 조성물
BR112015014250A2 (pt)	2012-12-18	2017-07-11	Glaxosmithkline Biologicals Sa	método para imunizar um bebê, vacina de combinação e, kit
ITMI20130142A1 (it)	2013-01-31	2014-08-01	Biosynth Srl	Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati
CN104151426A (zh) *	2013-05-14	2014-11-19	北京天成新脉生物技术有限公司	肺炎链球菌十三种荚膜多糖单克隆抗体及其应用
CN103495161B (zh) *	2013-10-08	2019-06-18	江苏康泰生物医学技术有限公司	一种多元肺炎球菌荚膜多糖-蛋白质结合物的混合物及其制备方法
SI3096783T1 (sl)	2014-01-21	2021-09-30	Pfizer Inc.	Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati
CN106102770B (zh)	2014-01-21	2022-03-22	辉瑞公司	包含缀合荚膜糖抗原的免疫原性组合物及其用途
US11160855B2 (en)	2014-01-21	2021-11-02	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
BR122023022294A2 (pt)	2014-01-21	2023-12-12	Pfizer Inc.	Uso de uma composição imunogênica que compreende um conjugado imunogênico compreendendo um polissacarídeo capsular isolado de streptococcus pneumoniae do sorotipo 15b
EP3104886B1 (de)	2014-02-14	2018-10-17	Pfizer Inc	Immunogene glykoproteinkonjugate
US9107906B1 (en)	2014-10-28	2015-08-18	Adma Biologics, Inc.	Compositions and methods for the treatment of immunodeficiency
FI3244917T3 (fi)	2015-01-15	2023-05-25	Pfizer	Immunogeenisiä koostumuksia pneumokokkirokotteissa käytettäväksi
JP6948951B2 (ja)	2015-05-04	2021-10-13	ファイザー・インク	Ｂ群レンサ球菌多糖−タンパク質コンジュゲート、コンジュゲートを生成するための方法、コンジュゲートを含む免疫原性組成物、およびそれらの使用
CN107810010A (zh)	2015-06-23	2018-03-16	生物E有限公司	多价肺炎球菌结合疫苗
IL303998A (en)	2015-07-21	2023-08-01	Pfizer	Immunogenic preparations containing conjugated capsular sugar antigens, kits containing them and their uses
KR20200038339A (ko) *	2015-09-10	2020-04-10	인벤트프라이즈 엘엘씨	다가 vlp 접합체
US10786561B2 (en)	2015-11-20	2020-09-29	Pfizer Inc.	Immunogenic compositions for use in pneumococcal vaccines
MX2019001341A (es)	2016-08-05	2019-07-04	Sanofi Pasteur Inc	Composicion de conjugado de polisacarido neumococico multivalente-proteina.
CN109862908B (zh) *	2016-08-05	2023-05-02	圣诺菲·帕斯图尔公司	多价肺炎球菌多糖-蛋白质缀合物组合物
JOP20190038B1 (ar) *	2016-09-06	2023-09-17	Lg Chemical Ltd	تركيب اقتراني من السكر المتعدد لكبسولة بكتيريا المكورات الرئوية وبروتين حامل واستخداماته
KR102608081B1 (ko) *	2016-09-30	2023-11-29	바이오로지칼 이 리미티드	폴리사카라이드-단백질 접합체를 포함하는 다가 폐렴구균 백신 조성물
US10751402B2 (en)	2016-11-09	2020-08-25	Pfizer Inc.	Immunogenic compositions and uses thereof
US11951165B2 (en)	2016-12-30	2024-04-09	Vaxcyte, Inc.	Conjugated vaccine carrier proteins
AU2017388891B2 (en) *	2016-12-30	2024-10-17	Vaxcyte, Inc.	Polypeptide-antigen conjugates with non-natural amino acids
PL3570879T3 (pl) *	2017-01-20	2022-06-20	Pfizer Inc.	Kompozycje immunogenne do zastosowania w szczepionkach przeciw pneumokokom
US11197921B2 (en)	2017-01-31	2021-12-14	Merck Sharp & Dohme Corp.	Methods for making polysaccharide-protein conjugates
WO2018144438A1 (en)	2017-01-31	2018-08-09	Merck Sharp & Dohme Corp.	Methods for production of capsular polysaccharide protein conjugates from streptococcus pneumoniae serotype 19f
WO2018144799A1 (en)	2017-02-03	2018-08-09	SCHADECK, Eva, Barbara	Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
WO2018156468A1 (en) *	2017-02-24	2018-08-30	Merck Sharp & Dohme Corp.	Pneumococcal conjugate vaccine formulations
JP2020514326A (ja)	2017-02-24	2020-05-21	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	肺炎連鎖球菌多糖−タンパク質コンジュゲートの免疫原性の増強
US10259865B2 (en)	2017-03-15	2019-04-16	Adma Biologics, Inc.	Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
KR102028693B1 (ko) *	2017-04-27	2019-10-04	주식회사 유바이오로직스	스트렙토코커스 뉴모니아 협막 다당체의 생산방법
US10729763B2 (en)	2017-06-10	2020-08-04	Inventprise, Llc	Mixtures of polysaccharide-protein pegylated compounds
CN118356485A (zh)	2017-06-10	2024-07-19	创赏公司	提供改善的免疫原性和亲合力的具有二价或多价缀合物多糖的多价缀合物疫苗
JP2020525540A (ja)	2017-06-23	2020-08-27	ノソコミアルヴァクスィーンコーポレイション	免疫原性組成物
EP3431168A1 (de) *	2017-07-19	2019-01-23	Bayer Aktiengesellschaft	Entfernen eines ungebundenen arzneimittels nach antikörperarzneimittelkonjugatkopplung
CN117736348A (zh) *	2017-09-07	2024-03-22	默沙东有限责任公司	肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
CN111065387B (zh)	2017-09-07	2023-08-25	默沙东有限责任公司	肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
LT3678654T (lt)	2017-09-07	2024-08-26	Merck Sharp & Dohme Llc	Pneumokokiniai polisacharidai ir jų panaudojimas imunogeninėse polisacharido ir baltymo nešiklio konjugatuose
AU2018328035B2 (en)	2017-09-07	2024-03-07	Chitrananda Abeygunawardana	Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
NZ765694A (en)	2017-12-06	2024-03-22	Merck Sharp & Dohme Llc	Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
IL276229B2 (en) *	2018-02-05	2024-01-01	Sanofi Pasteur Inc	A multivalent pneumococcal protein-polysaccharide conjugate preparation
WO2019152925A1 (en)	2018-02-05	2019-08-08	Sanofi Pasteur Inc.	Multivalent pneumococcal polysaccharide-protein conjugate composition
WO2019178364A2 (en) *	2018-03-14	2019-09-19	Elstar Therapeutics, Inc.	Multifunctional molecules and uses thereof
WO2019203599A1 (ko) *	2018-04-18	2019-10-24	에스케이바이오사이언스 주식회사	스트렙토코커스 뉴모니애 협막 다당류 및 그의 면역원성 접합체
WO2019212842A1 (en) *	2018-04-30	2019-11-07	Merck Sharp & Dohme Corp.	Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
CN112074293A (zh)	2018-04-30	2020-12-11	默沙东公司	生产肺炎链球菌荚膜多糖载体蛋白缀合物的方法
WO2019212844A1 (en)	2018-04-30	2019-11-07	Merck Sharp & Dohme Corp.	Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
WO2019220304A1 (en) *	2018-05-14	2019-11-21	Tergene Biotech Pvt. Ltd.	15 valent pneumococcal polysaccharide conjugate vaccine
WO2020010016A1 (en)	2018-07-04	2020-01-09	Sutrovax, Inc.	Self-adjuvanted immunogenic conjugates
CN112543649A (zh)	2018-07-04	2021-03-23	Vaxcyte公司	免疫原性缀合物的改进
WO2020010000A1 (en)	2018-07-04	2020-01-09	Sutrovax, Inc.	Improved methods for the preparation of immunogenic conjugates
US11260119B2 (en)	2018-08-24	2022-03-01	Pfizer Inc.	Escherichia coli compositions and methods thereof
KR20210093854A (ko) *	2018-09-12	2021-07-28	아피니백스, 인크.	다가 폐렴구균 백신
US20220143166A1 (en)	2018-10-12	2022-05-12	Biological E Limited	Multivalent pneumococcal polysaccharide-protein conjugate vaccine
CA3120922A1 (en)	2018-12-12	2020-06-18	Pfizer Inc.	Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
PE20211888A1 (es)	2018-12-19	2021-09-22	Merck Sharp & Dohme	Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y sus metodos de uso
JP7239509B6 (ja)	2019-02-22	2023-03-28	ファイザー・インク	細菌多糖類を精製するための方法
JP2022528158A (ja)	2019-04-10	2022-06-08	ファイザー・インク	コンジュゲート化莢膜糖抗原を含む免疫原性組成物、それを含むキットおよびその使用
CN110302375A (zh) *	2019-06-27	2019-10-08	康希诺生物股份公司	一种糖缀合物及其用途
AU2020323498A1 (en)	2019-07-31	2022-03-03	Sk Bioscience Co., Ltd.	Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
CN112741901B (zh) *	2019-10-31	2024-05-10	北京科兴中维生物技术有限公司	一种含有5型肺炎链球菌荚膜多糖的疫苗及其制备方法
US20230000966A1 (en)	2019-11-01	2023-01-05	Pfizer Inc.	Escherichia coli compositions and methods thereof
WO2021146681A1 (en) *	2020-01-17	2021-07-22	Inventprise, Llc	Multivalent streptococcus vaccines
AU2021224078B2 (en)	2020-02-21	2024-01-18	Pfizer Inc.	Purification of saccharides
CA3173729A1 (en)	2020-02-23	2021-08-26	Pfizer Inc.	Escherichia coli compositions and methods thereof
EP4192499A4 (de)	2020-08-10	2024-09-25	Inventprise Inc	Multivalente pneumokokken-glykokonjugat-impfstoffe, die nachkommende serotyp 24f enthalten
US20230321212A1 (en)	2020-08-26	2023-10-12	Pfizer Inc.	Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
GB202016165D0 (en)	2020-10-12	2020-11-25	Optivalent Ltd	Vaccine
JP2023546446A (ja)	2020-10-22	2023-11-02	ファイザー・インク	細菌多糖を精製する方法
IL302362A (en)	2020-10-27	2023-06-01	Pfizer	ESCHERICHIA COLI preparations and their methods
MX2023005221A (es)	2020-11-04	2023-05-16	Pfizer	Composiciones inmunogenicas para uso en vacunas neumococicas.
US20230405137A1 (en)	2020-11-10	2023-12-21	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
US20220202923A1 (en)	2020-12-23	2022-06-30	Pfizer Inc.	E. coli fimh mutants and uses thereof
KR102610292B1 (ko) *	2021-02-10	2023-12-04	에스케이바이오사이언스(주)	스트랩토코커스 뉴모니애 다당류와 운반체 단백질의 접합체 제조 방법
WO2022234416A1 (en)	2021-05-03	2022-11-10	Pfizer Inc.	Vaccination against pneumoccocal and covid-19 infections
EP4333879A1 (de)	2021-05-03	2024-03-13	Pfizer Inc.	Impfung gegen bakterielle und betacoronavirus-infektionen
JP2024521847A (ja)	2021-05-28	2024-06-04	ファイザー・インク	コンジュゲート化莢膜糖抗原を含む免疫原性組成物およびその使用
IL308902A (en)	2021-05-28	2024-01-01	Pfizer	Immune preparations containing conjugated sugar antigens and their uses
US12036276B2 (en)	2021-09-09	2024-07-16	Affinivax, Inc.	Multivalent pneumococcal vaccines
CN114106210A (zh) *	2021-11-09	2022-03-01	北京智飞绿竹生物制药有限公司	一种23价肺炎球菌多糖疫苗的生产工艺
MX2024008039A (es)	2022-01-13	2024-07-10	Pfizer	Composiciones inmunogenicas que comprenden antigenos de sacaridos capsulares conjugados y usos de los mismos.
GB2614916A (en)	2022-01-25	2023-07-26	Optivalent Ltd	Intradermal vaccine complement
WO2023161817A1 (en)	2022-02-25	2023-08-31	Pfizer Inc.	Methods for incorporating azido groups in bacterial capsular polysaccharides
WO2023218322A1 (en)	2022-05-11	2023-11-16	Pfizer Inc.	Process for producing of vaccine formulations with preservatives
WO2024062494A1 (en)	2022-09-19	2024-03-28	Biological E Limited	Method for the purification of capsular polysaccharides
WO2024084397A1 (en)	2022-10-19	2024-04-25	Pfizer Inc.	Vaccination against pneumoccocal and covid-19 infections
WO2024110827A1 (en)	2022-11-21	2024-05-30	Pfizer Inc.	Methods for preparing conjugated capsular saccharide antigens and uses thereof
WO2024110839A2 (en)	2022-11-22	2024-05-30	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024116096A1 (en)	2022-12-01	2024-06-06	Pfizer Inc.	Pneumococcal conjugate vaccine formulations
WO2024166008A1 (en)	2023-02-10	2024-08-15	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024201324A2 (en)	2023-03-30	2024-10-03	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024214016A1 (en)	2023-04-14	2024-10-17	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024224266A1 (en)	2023-04-24	2024-10-31	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof

Family Cites Families (102)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US37741A (en)		1863-02-24		Improvement in bee-hives
US4097666A (en)	1976-04-29	1978-06-27	The Institute Of Paper Chemistry	Solvent system for polysaccharides
CA1115210A (en)	1977-11-28	1981-12-29	Dennis J. Carlo	Pneumococcal vaccine
US4372945A (en)	1979-11-13	1983-02-08	Likhite Vilas V	Antigen compounds
US4356170A (en)	1981-05-27	1982-10-26	Canadian Patents & Development Ltd.	Immunogenic polysaccharide-protein conjugates
BE889979A (fr)	1981-08-14	1982-02-15	Smith Kline Rit	Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
US5097020A (en)	1983-07-05	1992-03-17	The University Of Rochester	Immunogenic conjugates
US5360897A (en) *	1981-08-31	1994-11-01	The University Of Rochester	Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
US4673574A (en)	1981-08-31	1987-06-16	Anderson Porter W	Immunogenic conjugates
US4902506A (en)	1983-07-05	1990-02-20	The University Of Rochester	Immunogenic conjugates
US4619828A (en)	1982-07-06	1986-10-28	Connaught Laboratories, Inc.	Polysaccharide exotoxoid conjugate vaccines
CH660375A5 (it)	1983-02-08	1987-04-15	Sclavo Spa	Procedimento per la produzione di proteine correlate alla tossina difterica.
US4762713A (en) *	1983-07-05	1988-08-09	The University Of Rochester	Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers
US4761283A (en) *	1983-07-05	1988-08-02	The University Of Rochester	Immunogenic conjugates
US4808700A (en) *	1984-07-09	1989-02-28	Praxis Biologics, Inc.	Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
IT1187753B (it)	1985-07-05	1987-12-23	Sclavo Spa	Coniugati glicoproteici ad attivita' immunogenica trivalente
US5110908A (en)	1986-12-31	1992-05-05	Praxis Biologics, Inc.	Haemophilus influenzae peptides and proteins
US5057540A (en)	1987-05-29	1991-10-15	Cambridge Biotech Corporation	Saponin adjuvant
US4912094B1 (en)	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
DE69012318T2 (de)	1989-03-09	1995-03-09	Praxis Biologics, Inc., Rochester, N.Y.	Impfstoffe gegen hämophilus influenzae.
HU212924B (en)	1989-05-25	1996-12-30	Chiron Corp	Adjuvant formulation comprising a submicron oil droplet emulsion
SE466259B (sv)	1990-05-31	1992-01-20	Arne Forsgren	Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
US5153312A (en)	1990-09-28	1992-10-06	American Cyanamid Company	Oligosaccharide conjugate vaccines
CA2059692C (en) *	1991-01-28	2004-11-16	Peter J. Kniskern	Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en) *	1991-01-28	2003-08-19	Peter J. Kniskern	Polysaccharide antigens from streptococcus pneumoniae
IL101715A (en)	1991-05-02	2005-06-19	Amgen Inc	Recombinant dna-derived cholera toxin subunit analogs
US5552146A (en)	1991-08-15	1996-09-03	Board Of Regents, The University Of Texas System	Methods and compositions relating to useful antigens of Moraxella catarrhalis
US5769047A (en)	1991-12-23	1998-06-23	Zoche; Michael	Engine with oil separator
IT1253009B (it)	1991-12-31	1995-07-10	Sclavo Ricerca S R L	Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
DK0616034T3 (da)	1993-03-05	2005-02-21	Wyeth Corp	Plasmid til fremstilling af CRM-protein og diphtheria toxin
EP0720485B1 (de)	1993-09-22	2003-11-19	Henry M. Jackson Foundation For The Advancement Of Military Medicine	Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
US5712118A (en)	1993-09-29	1998-01-27	Research Foundation Of State University Of New York	Vaccine for branhamella catarrhalis
US5770213A (en)	1994-05-05	1998-06-23	American Cyanamid Company	Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection
US5607846A (en)	1994-05-17	1997-03-04	Research Foundation Of State University Of New York	Vaccine for moraxella catarrhalis
US6207646B1 (en)	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US5643725A (en)	1994-07-19	1997-07-01	American Cyanamid Company	Sequence and analysis of LKP pilin structural genes and the LKP pili operon of nontypable haemophilus influenzae
US5565204A (en)	1994-08-24	1996-10-15	American Cyanamid Company	Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US6676948B2 (en)	1994-08-25	2004-01-13	Washington University	Haemophilus adherence and penetration proteins
US6245337B1 (en)	1994-08-25	2001-06-12	Washington University	Haemophilus adherence and penetration proteins
US5714354A (en)	1995-06-06	1998-02-03	American Home Products Corporation	Alcohol-free pneumococcal polysaccharide purification process
US5695768A (en) *	1995-06-07	1997-12-09	Alberta Research Council	Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
US7341727B1 (en)	1996-05-03	2008-03-11	Emergent Product Development Gaithersburg Inc.	M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
DE69730814T2 (de)	1996-07-26	2005-09-29	Wyeth Holdings Corp.	Das NucA Protein von Haemophilus influenzae und dessen kodierendes Gen
ATE497004T1 (de)	1996-12-20	2011-02-15	Univ Texas	Moraxella catarrhalis antigene uspa1 und uspa2
DK1005487T3 (da)	1997-01-31	2006-11-13	Wyeth Corp	Ydre 74 kD-membranprotein fra Moraxella catarrhalis
US6113918A (en)	1997-05-08	2000-09-05	Ribi Immunochem Research, Inc.	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
FR2763244B1 (fr)	1997-05-14	2003-08-01	Pasteur Merieux Serums Vacc	Composition vaccinale multivalente a porteur mixte
ATE468403T2 (de) *	1997-12-23	2010-06-15	Baxter Healthcare Sa	Verfahren zur extraktion und isolierung von bakteriellen hüllpolysacchariden zur verwendung als vakzine oder, an proteine gekoppelt, als konjugierte vakzine
WO1999040936A2 (en) *	1998-02-12	1999-08-19	American Cyanamid Company	Pneumococcal and meningococcal vaccines formulated with interleukin-12
US7018637B2 (en)	1998-02-23	2006-03-28	Aventis Pasteur, Inc	Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
CA2233725A1 (en) *	1998-03-31	1999-09-30	Hemosol Inc.	Hemoglobin-hydroxyethyl starch complexes
US7227011B2 (en)	1998-06-04	2007-06-05	United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention	Nucleic acid vaccines for prevention of flavivirus infection
IL142017A0 (en)	1998-09-24	2002-03-10	Univ Minnesota	Human complement c3-degrading polypeptide from streptococcus pneumoniae
CA2344740C (en)	1998-09-30	2011-11-22	American Cyanamid Company	Mutant cholera holotoxin as an adjuvant
EP1034792A1 (de)	1999-03-11	2000-09-13	Pasteur Merieux Serums Et Vaccins	Intranasale Verabreichung von Pneumokokken-Polysaccharid Impfstoffen
EP1035137A1 (de)	1999-03-12	2000-09-13	Pasteur Merieux Serums Et Vaccins	Verfahren zur reduktiven aminierung von polysacchariden
GB9909077D0 (en) *	1999-04-20	1999-06-16	Smithkline Beecham Biolog	Novel compositions
AU750788B2 (en) *	1999-03-19	2002-07-25	Smithkline Beecham Biologicals (Sa)	Vaccine
DE60044352D1 (de)	1999-06-25	2010-06-17	Wyeth Corp	Herstellung der lipid-modifizierten form des peptidoglykan-assoziierten lipoproteins aus gram-negativen bakterien
GB0011108D0 (en)	2000-05-08	2000-06-28	Microscience Ltd	Virulence gene and protein and their use
GB0012079D0 (en)	2000-05-18	2000-07-12	Microscience Ltd	Virulence gene and protein, and their use
PL393584A1 (pl)	2000-06-29	2011-05-23	Glaxosmithkline Biologicals S.A.	Szczepionka
GB0108364D0 (en)	2001-04-03	2001-05-23	Glaxosmithkline Biolog Sa	Vaccine composition
GB0020952D0 (en)	2000-08-24	2000-10-11	Microscience Ltd	Genes and proteins and their uses
GB0022742D0 (en) *	2000-09-15	2000-11-01	Smithkline Beecham Biolog	Vaccine
ATE267767T1 (de)	2000-12-13	2004-06-15	Sca Hygiene Prod Zeist Bv	Rückgewinnungsprozess für gebrauchtes periodat
WO2002053761A2 (en)	2000-12-28	2002-07-11	Wyeth	Recombinant protective protein from $i(streptococcus pneumoniae)
BR0208944A (pt)	2001-04-16	2006-10-10	Wyeth Corp	quadros de leitura aberta de streptococus pneumoniae codificando os antìgenos de polipeptìdeos e seus usos
ATE451386T1 (de)	2001-06-07	2009-12-15	Wyeth Corp	Mutantenformen von cholera holotoxin als adjuvans
CN1541111A (zh)	2001-06-07	2004-10-27	��Ͽع��޹�˾	作为佐剂的霍乱全毒素的突变形式
GB0115176D0 (en)	2001-06-20	2001-08-15	Chiron Spa	Capular polysaccharide solubilisation and combination vaccines
WO2003009869A1 (en)	2001-07-26	2003-02-06	Chiron Srl.	Vaccines comprising aluminium adjuvants and histidine
MX339524B (es)	2001-10-11	2016-05-30	Wyeth Corp	Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
WO2003048304A2 (en)	2001-11-29	2003-06-12	Wyeth Holdings Corporation	ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF
GB0130215D0 (en) *	2001-12-18	2002-02-06	Glaxosmithkline Biolog Sa	Vaccine
NZ535754A (en)	2002-03-15	2007-01-26	Wyeth Corp	Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
AU2002309259A1 (en)	2002-05-09	2003-11-11	Massimo Porro	Improved polysaccharide and glycoconjugate vaccines_____________
AU2003257003A1 (en)	2002-07-30	2004-02-16	Baxter Healthcare S.A.	Chimeric multivalent polysaccharide conjugate vaccines
AU2003270779A1 (en)	2002-09-20	2004-04-08	The United States Of America As Represented By The Secretary Of Agriculture	Vaccine compositions and adjuvant
FR2850106B1 (fr) *	2003-01-17	2005-02-25	Aventis Pasteur	Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
WO2004083251A2 (en)	2003-03-17	2004-09-30	Wyeth Holdings Corporation	Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
BRPI0409459A (pt)	2003-04-16	2006-05-02	Wyeth Corp	novas composições imunogênicas para a prevenção e tratamento de doença meningocócica
CN1241937C (zh) *	2003-07-04	2006-02-15	上海健益科技发展有限公司	多价肺炎球菌多糖结合疫苗
EP1651261B1 (de)	2003-08-06	2014-10-08	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Polysaccharid-protein-konjugat-vakzine
ATE460498T1 (de)	2003-09-11	2010-03-15	Staat Der Nederlanden Vert Doo	Verfahren zur herstellung eines kapselpolysaccharids zur verwendung in konjugat- impfstoffen
FR2857364B1 (fr)	2003-12-08	2005-09-23	Aventis Pasteur	Dosage des acides techoiques des bacteries gram+
PL1701968T3 (pl)	2003-12-17	2015-11-30	Wyeth Llc	Koniugaty nośników z peptydami immunogennymi i sposoby ich wytwarzania
US20060022838A1 (en)	2004-07-27	2006-02-02	Fisher Richard A	Speed limit indicia for traffic signals
US7955605B2 (en)	2005-04-08	2011-06-07	Wyeth Llc	Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en)	2005-04-08	2007-08-09	Wyeth	Multivalent pneumococcal polysaccharide-protein conjugate composition
WO2006110381A1 (en) *	2005-04-08	2006-10-19	Wyeth	Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en)	2005-04-08	2010-05-04	Wyeth Llc	Multivalent pneumococcal polysaccharide-protein conjugate composition
SI2384765T1 (sl)	2005-12-22	2017-03-31	Glaxosmithkline Biologicals S.A.	Streptococcus pneumoniae vakcina
CA2664799C (en)	2006-09-29	2016-01-05	Japan Poliomyelitis Research Institute	Ipv-dpt vaccine
MX2009013949A (es)	2007-06-26	2010-05-24	Glaxosmithkline Biolog Sa	Vacuna que comprende conjugados de polisacárido capsular de streptococcus pneumoniae.
SG188813A1 (en)	2007-12-24	2013-04-30	Id Biomedical Corp Quebec	Recombinant rsv antigens
TW201136603A (en)	2010-02-09	2011-11-01	Merck Sharp & Amp Dohme Corp	15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
KR102057217B1 (ko)	2012-06-20	2020-01-22	에스케이바이오사이언스 주식회사	다가 폐렴구균 다당류-단백질 접합체 조성물
KR20140075201A (ko)	2012-12-11	2014-06-19	에스케이케미칼주식회사	다가 폐렴구균 다당류-단백질 접합체 조성물
KR20140075196A (ko)	2012-12-11	2014-06-19	에스케이케미칼주식회사	다가 폐렴구균 다당류-단백질 접합체 조성물
CN106102770B (zh)	2014-01-21	2022-03-22	辉瑞公司	包含缀合荚膜糖抗原的免疫原性组合物及其用途
JP2020514326A (ja) *	2017-02-24	2020-05-21	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	肺炎連鎖球菌多糖−タンパク質コンジュゲートの免疫原性の増強

2006
- 2006-03-31 WO PCT/US2006/012354 patent/WO2006110381A1/en active Application Filing
- 2006-03-31 EP EP11188659A patent/EP2425853A1/de not_active Withdrawn
- 2006-03-31 CA CA2878579A patent/CA2878579C/en active Active
- 2006-03-31 EP EP11188674A patent/EP2425855A1/de not_active Withdrawn
- 2006-03-31 KR KR1020157012737A patent/KR101730750B1/ko active IP Right Grant
- 2006-03-31 KR KR1020137007564A patent/KR101588939B1/ko active IP Right Review Request
- 2006-03-31 EP EP11188654A patent/EP2425852A1/de not_active Withdrawn
- 2006-03-31 NZ NZ562406A patent/NZ562406A/en unknown
- 2006-03-31 ME MEP-2012-39A patent/ME01334B/me unknown
- 2006-03-31 CN CN201810299488.0A patent/CN108404126B/zh active Active
- 2006-03-31 MX MX2015010176A patent/MX358148B/es unknown
- 2006-03-31 EP EP21211242.9A patent/EP4005595A1/de active Pending
- 2006-03-31 IL IL308456A patent/IL308456A/en unknown
- 2006-03-31 KR KR1020227009488A patent/KR102564388B1/ko active IP Right Grant
- 2006-03-31 AT AT06740419T patent/ATE548051T1/de active
- 2006-03-31 CA CA2604363A patent/CA2604363C/en active Active
- 2006-03-31 CA CA3165042A patent/CA3165042A1/en active Pending
- 2006-03-31 EP EP11188668A patent/EP2425854A1/de not_active Withdrawn
- 2006-03-31 RS RS20120142A patent/RS52249B/en unknown
- 2006-03-31 KR KR1020157012734A patent/KR101730748B1/ko active IP Right Grant
- 2006-03-31 KR KR1020077025884A patent/KR101298053B1/ko active IP Right Review Request
- 2006-03-31 KR KR1020217005073A patent/KR102378962B1/ko active IP Right Grant
- 2006-03-31 TW TW095111520A patent/TWI386222B/zh active
- 2006-03-31 CN CN2006800177768A patent/CN101180079B/zh active Active
- 2006-03-31 CN CN202110498760.XA patent/CN113198012B/zh active Active
- 2006-03-31 EP EP11188679A patent/EP2425856A1/de not_active Withdrawn
- 2006-03-31 JP JP2008505426A patent/JP4472770B2/ja active Active
- 2006-03-31 PT PT06740419T patent/PT1868645E/pt unknown
- 2006-03-31 EP EP11188651A patent/EP2425851A1/de not_active Withdrawn
- 2006-03-31 CA CA2986862A patent/CA2986862C/en active Active
- 2006-03-31 MX MX2007012336A patent/MX2007012336A/es active IP Right Grant
- 2006-03-31 BR BRPI0607025A patent/BRPI0607025B8/pt active IP Right Grant
- 2006-03-31 CN CN201510187769.3A patent/CN104815327A/zh active Pending
- 2006-03-31 KR KR1020197025300A patent/KR102220506B1/ko active IP Right Grant
- 2006-03-31 US US11/395,593 patent/US20060228380A1/en not_active Abandoned
- 2006-03-31 KR KR1020157012736A patent/KR101730749B1/ko active IP Right Grant
- 2006-03-31 SI SI200631301T patent/SI1868645T1/sl unknown
- 2006-03-31 KR KR1020237026417A patent/KR102611449B1/ko active IP Right Grant
- 2006-03-31 PL PL06740419T patent/PL1868645T3/pl unknown
- 2006-03-31 EP EP17196004.0A patent/EP3311836A1/de not_active Ceased
- 2006-03-31 ES ES06740419T patent/ES2382048T3/es active Active
- 2006-03-31 CN CN201210192553.2A patent/CN102716480B/zh active Active
- 2006-03-31 AU AU2006235013A patent/AU2006235013B2/en active Active
- 2006-03-31 TW TW103115112A patent/TWI511739B/zh active
- 2006-03-31 KR KR1020157012735A patent/KR20150061019A/ko not_active Application Discontinuation
- 2006-03-31 CN CN202110498952.0A patent/CN113198013B/zh active Active
- 2006-03-31 EP EP06740419A patent/EP1868645B1/de not_active Revoked
- 2006-03-31 DK DK06740419.4T patent/DK1868645T3/da active
- 2006-03-31 TW TW100146297A patent/TWI445545B/zh active
- 2006-03-31 KR KR1020177019847A patent/KR102017842B1/ko active IP Right Grant
- 2006-04-07 AR ARP060101395A patent/AR053354A1/es not_active Application Discontinuation
- 2006-04-07 MY MYPI20061589A patent/MY145150A/en unknown
- 2006-09-13 SA SA6270323A patent/SA06270323B1/ar unknown
2007
- 2007-10-04 MX MX2019008863A patent/MX2019008863A/es unknown
- 2007-10-07 IL IL186367A patent/IL186367A/en active IP Right Grant
- 2007-11-02 ZA ZA200709483A patent/ZA200709483B/xx unknown
2008
- 2008-11-07 HK HK08112248.7A patent/HK1120416A1/xx unknown
2009
- 2009-01-22 US US12/357,853 patent/US8895024B2/en active Active
- 2009-04-24 JP JP2009106688A patent/JP5173920B2/ja active Active
2012
- 2012-03-22 CY CY20121100301T patent/CY1112777T1/el unknown
- 2012-03-29 HR HR20120278T patent/HRP20120278T1/hr unknown
- 2012-04-04 US US13/439,111 patent/US8808708B2/en active Active
- 2012-10-10 JP JP2012225307A patent/JP5730261B2/ja active Active
2013
- 2013-08-20 IL IL228035A patent/IL228035A0/en unknown
2014
- 2014-07-02 US US14/322,057 patent/US9399060B2/en active Active
2016
- 2016-02-02 HK HK16101175.7A patent/HK1213184A1/zh unknown
- 2016-02-12 US US15/042,189 patent/US9981035B2/en active Active
- 2016-03-10 CL CL2016000566A patent/CL2016000566A1/es unknown
- 2016-12-07 AR ARP160103764A patent/AR107018A2/es not_active Application Discontinuation
2017
- 2017-08-31 CL CL2017002206A patent/CL2017002206A1/es unknown
2018
- 2018-05-07 US US15/972,953 patent/US10780160B2/en active Active
2019
- 2019-01-09 HK HK19100324.6A patent/HK1257962A1/zh unknown
- 2019-06-05 IL IL267125A patent/IL267125B/en active IP Right Grant
- 2019-08-01 US US16/528,680 patent/US11191830B2/en active Active
2020
- 2020-02-19 US US16/794,315 patent/US10716848B2/en active Active
2021
- 2021-04-26 IL IL282638A patent/IL282638A/en unknown
- 2021-05-24 US US17/328,657 patent/US20210283247A1/en active Pending

Also Published As

Publication number	Publication date
US20090130137A1 (en)	2009-05-21
EP2425852A1 (de)	2012-03-07
IL267125A (en)	2019-08-29
US20200179508A1 (en)	2020-06-11
CN104815327A (zh)	2015-08-05
KR20130048262A (ko)	2013-05-09
KR20150061019A (ko)	2015-06-03
US8808708B2 (en)	2014-08-19
KR20150061020A (ko)	2015-06-03
RS52249B (en)	2012-10-31
CN108404126A (zh)	2018-08-17
ATE548051T1 (de)	2012-03-15
CA2986862A1 (en)	2006-10-19
KR20210022768A (ko)	2021-03-03
CN113198012A (zh)	2021-08-03
TW201212937A (en)	2012-04-01
KR20150061021A (ko)	2015-06-03
CN113198012B (zh)	2024-09-17
AR107018A2 (es)	2018-03-14
EP2425851A1 (de)	2012-03-07
EP4005595A1 (de)	2022-06-01
AU2006235013A1 (en)	2006-10-19
HK1257962A1 (zh)	2019-11-01
TWI445545B (zh)	2014-07-21
KR102378962B1 (ko)	2022-03-28
CA2878579A1 (en)	2006-10-19
US20160158345A1 (en)	2016-06-09
KR101730748B1 (ko)	2017-04-26
MX2019008863A (es)	2019-09-13
SI1868645T1 (sl)	2012-04-30
CA3165042A1 (en)	2006-10-19
CA2604363A1 (en)	2006-10-19
CA2604363C (en)	2015-06-16
US8895024B2 (en)	2014-11-25
IL186367A0 (en)	2008-01-20
ZA200709483B (en)	2009-03-25
IL282638A (en)	2021-06-30
KR20070118700A (ko)	2007-12-17
CN113198013B (zh)	2024-02-20
DK1868645T3 (da)	2012-04-10
US20180250390A1 (en)	2018-09-06
BRPI0607025B1 (pt)	2019-11-12
KR102017842B1 (ko)	2019-09-03
CN101180079A (zh)	2008-05-14
EP2425854A1 (de)	2012-03-07
AU2006235013B2 (en)	2011-11-03
TWI511739B (zh)	2015-12-11
ME01334B (me)	2013-12-20
US20210283247A1 (en)	2021-09-16
MX358148B (es)	2018-08-07
US11191830B2 (en)	2021-12-07
CY1112777T1 (el)	2016-02-10
BRPI0607025B8 (pt)	2021-05-25
PT1868645E (pt)	2012-05-17
TW200719911A (en)	2007-06-01
EP1868645A1 (de)	2007-12-26
TWI386222B (zh)	2013-02-21
KR102220506B1 (ko)	2021-03-02
US9981035B2 (en)	2018-05-29
KR101730750B1 (ko)	2017-04-26
EP2425853A1 (de)	2012-03-07
AR053354A1 (es)	2007-05-02
US9399060B2 (en)	2016-07-26
US20060228380A1 (en)	2006-10-12
EP1868645B1 (de)	2012-03-07
KR102564388B1 (ko)	2023-08-08
JP5173920B2 (ja)	2013-04-03
WO2006110381A1 (en)	2006-10-19
US10716848B2 (en)	2020-07-21
US20140314805A1 (en)	2014-10-23
JP2009161567A (ja)	2009-07-23
HK1120416A1 (en)	2009-04-03
IL267125B (en)	2021-05-31
HK1213184A1 (zh)	2016-06-30
BRPI0607025A2 (pt)	2009-07-28
EP2425855A1 (de)	2012-03-07
US20190388537A1 (en)	2019-12-26
CA2878579C (en)	2018-01-23
KR20190104241A (ko)	2019-09-06
CN102716480A (zh)	2012-10-10
IL228035A0 (en)	2013-09-30
CA2986862C (en)	2022-09-27
MY145150A (en)	2011-12-30
JP5730261B2 (ja)	2015-06-03
EP2425856A1 (de)	2012-03-07
JP2008535838A (ja)	2008-09-04
JP2013006881A (ja)	2013-01-10
IL186367A (en)	2013-09-30
IL308456A (en)	2024-01-01
KR102611449B1 (ko)	2023-12-06
TW201438734A (zh)	2014-10-16
CN113198013A (zh)	2021-08-03
KR101730749B1 (ko)	2017-04-26
KR20150061018A (ko)	2015-06-03
CN108404126B (zh)	2022-10-18
CL2017002206A1 (es)	2018-03-23
KR20230118200A (ko)	2023-08-10
US10780160B2 (en)	2020-09-22
KR20170086139A (ko)	2017-07-25
EP3311836A1 (de)	2018-04-25
PL1868645T3 (pl)	2012-07-31
ES2382048T3 (es)	2012-06-04
KR20220042483A (ko)	2022-04-05
US20120237542A1 (en)	2012-09-20
CL2016000566A1 (es)	2016-10-28
SA06270323B1 (ar)	2010-10-05
CN102716480B (zh)	2023-03-21
KR101298053B1 (ko)	2013-08-20
MX2007012336A (es)	2007-11-21
NZ562406A (en)	2009-09-25
CN101180079B (zh)	2012-07-18
KR101588939B1 (ko)	2016-01-26
JP4472770B2 (ja)	2010-06-02

Publication	Publication Date	Title
HRP20120278T1 (hr)	2012-04-30	Polivalentni pripravak konjugata pneumokoknog polisaharida s proteinom
RU2015100140A (ru)	2016-08-10	Поливалентная композиция, содержащая конъюгаты пневмококковый полисахарид-белок
RU2012138368A (ru)	2014-03-20	15-валентная вакцинная композиция на основе конъюгата пневмококкового полисахарида с белком
JP2020533437A5 (de)	2021-08-19
RU2015121771A (ru)	2017-01-19	Мультивалентная композиция на основе конъюгатов пневмококковый полисахарид-белок
MX2009006548A (es)	2009-06-26	Composicion conjugada polisacarido-proteina neumococica multivalente.
IL276230B2 (en)	2024-01-01	A multivalent pneumococcal protein-polysaccharide conjugate preparation
JP2020533439A5 (de)	2021-08-19
MX2009006547A (es)	2009-06-26	Composicion conjugada polisacarido-proteina neumococica multivalente.
TR201900418T4 (tr)	2019-02-21	Pnömokok polisakkarit konjugat aşısı.
JP2020533438A5 (de)	2021-08-19
JP2020533442A5 (de)	2021-08-19
HRP20210373T1 (hr)	2021-04-30	Multivalentno pneumokokno konjugirano cjepivo
MX2009013949A (es)	2010-05-24	Vacuna que comprende conjugados de polisacárido capsular de streptococcus pneumoniae.
MX2009006705A (es)	2009-06-30	Composicion conjugada polisacarido-proteina neumococica multivalente.
HRP20190198T4 (hr)	2024-10-25	Formulacije koje stabiliziraju i inhibiraju taloženje imunogenih pripravaka
AR084158A1 (es)	2013-04-24	Formulaciones que mitigan la agregacion inducida por agitacion de composiciones inmunogenicas
RU2020112314A (ru)	2021-10-07	Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель
RU2020112312A (ru)	2021-10-07	Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель
RU2022129006A (ru)	2022-11-23	Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель
RU2020112309A (ru)	2021-10-07	Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель
RU2020112308A (ru)	2021-10-07	Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель
RU2023120100A (ru)	2023-08-09	Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель